liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
In situ assembly of an injectable cardiac stimulator
Lund Univ, Sweden.
Univ Gothenburg, Sweden.
Lund Univ, Sweden.
Linköping University, Department of Science and Technology, Laboratory of Organic Electronics. Linköping University, Faculty of Science & Engineering.ORCID iD: 0000-0001-5757-8565
Show others and affiliations
2024 (English)In: Nature Communications, E-ISSN 2041-1723, Vol. 15, no 1, article id 6774Article in journal (Refereed) Published
Abstract [en]

Without intervention, cardiac arrhythmias pose a risk of fatality. However, timely intervention can be challenging in environments where transporting a large, heavy defibrillator is impractical, or emergency surgery to implant cardiac stimulation devices is not feasible. Here, we introduce an injectable cardiac stimulator, a syringe loaded with a nanoparticle solution comprising a conductive polymer and a monomer that, upon injection, forms a conductive structure around the heart for cardiac stimulation. Following treatment, the electrode is cleared from the body, eliminating the need for surgical extraction. The mixture adheres to the beating heart in vivo without disrupting its normal rhythm. The electrofunctionalized injectable cardiac stimulator demonstrates a tissue-compatible Young's modulus of 21 kPa and a high conductivity of 55 S/cm. The injected electrode facilitates electrocardiogram measurements, regulates heartbeat in vivo, and rectifies arrhythmia. Conductive functionality is maintained for five consecutive days, and no toxicity is observed at the organism, organ, or cellular levels. Heart pacing devices are bulky or rely on surgery. Here, the authors present an injectable cardiac stimulator based on a nanoparticle solution which attaches to the heart and forms a conductive path to the skin for external connection. It can regulate heartbeats and is thereafter cleared from the body.

Place, publisher, year, edition, pages
NATURE PORTFOLIO , 2024. Vol. 15, no 1, article id 6774
National Category
Cardiology and Cardiovascular Disease
Identifiers
URN: urn:nbn:se:liu:diva-207192DOI: 10.1038/s41467-024-51111-4ISI: 001287600900043PubMedID: 39117721OAI: oai:DiVA.org:liu-207192DiVA, id: diva2:1894952
Note

Funding Agencies|Vetenskapsrdet (Swedish Research Council); Lund University Strategic Research Areas MultiPark; NanoLund; Lund University Bioimaging Center [2023-04965, 2021-05231]; Swedish Research Council [RMX18-0083]; Swedish Foundation for Strategic Research [AdG 2018, 834677]; European Research Council; Swedish Research Council (R.O.) [0087092]; Novo Nordisk Foundation Distinguished Innovator Grant

Available from: 2024-09-04 Created: 2024-09-04 Last updated: 2025-02-10

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Strakosas, XenofonBerggren, Magnus
By organisation
Laboratory of Organic ElectronicsFaculty of Science & Engineering
In the same journal
Nature Communications
Cardiology and Cardiovascular Disease

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 112 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf